ProPhase Labs (PRPH) News Today $0.77 -0.01 (-1.28%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comProPhase Labs, Inc. Reports Financial Results and Strategic DevelopmentsProPhase Labs, Inc. (NASDAQ: PRPH) recently disclosed its financial performance for the quarter ending September 30, 2024, through a press release. In an announcement dated NovemNovember 16, 2024 | americanbankingnews.comProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comAnalyzing Arcutis Biotherapeutics (NASDAQ:ARQT) and ProPhase Labs (NASDAQ:PRPH)November 15, 2024 | americanbankingnews.comProPhase Labs: Strategic Moves for Future GrowthNovember 14, 2024 | markets.businessinsider.comProPhase Labs Announces Closing of Public Offering of Common StockNovember 13, 2024 | markets.businessinsider.comProPhase Labs Announces Proposed Public Offering of Common StockNovember 11, 2024 | theglobeandmail.comProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024November 11, 2024 | globenewswire.comProPhase Labs announces common stock offering, no amount givenNovember 9, 2024 | markets.businessinsider.comProPhase Labs 4.17M share Spot Secondary priced at $.72November 8, 2024 | markets.businessinsider.comProPhase Labs Announces Pricing of Public Offering of Common StockNovember 7, 2024 | globenewswire.comProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced AncestryNovember 4, 2024 | markets.businessinsider.comProPhase Labs (NASDAQ:PRPH) Stock, Short Interest ReportOctober 28, 2024 | benzinga.comProPhase Labs to Present at the 2024 ThinkEquity ConferenceOctober 22, 2024 | markets.businessinsider.comProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025October 17, 2024 | finanznachrichten.deProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025October 17, 2024 | globenewswire.comProPhase Labs (NASDAQ:PRPH) Stock, Insider Trading ActivityOctober 9, 2024 | benzinga.comProPhase Labs announces change in accounting firmOctober 6, 2024 | uk.investing.comDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)August 27, 2024 | globenewswire.comProPhase Labs secures $10M in amended note agreementAugust 24, 2024 | uk.investing.comProPhase Labs to Present at August 20th Virtual Investor Summit Microcap EventAugust 19, 2024 | globenewswire.comProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comPROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14August 7, 2024 | globenewswire.comProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. ProgressJuly 11, 2024 | globenewswire.comProPhase Labs (NASDAQ:PRPH) Lifted to "Sell" at StockNews.comStockNews.com upgraded shares of ProPhase Labs to a "sell" rating in a research report on Wednesday.June 26, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Stock Passes Below 200-Day Moving Average of $5.11ProPhase Labs (NASDAQ:PRPH) Stock Crosses Below 200 Day Moving Average of $5.11June 25, 2024 | marketbeat.comShort Interest in ProPhase Labs, Inc. (NASDAQ:PRPH) Grows By 20.8%ProPhase Labs, Inc. (NASDAQ:PRPH - Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 314,200 shares, an increase of 20.8% from the May 15th total of 260,100 shares. Based on an average daily volume of 60,100 shares, the short-interest ratio is currently 5.2 days.June 16, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Stock Price Passes Above Two Hundred Day Moving Average of $5.10ProPhase Labs (NASDAQ:PRPH) Shares Pass Above 200-Day Moving Average of $5.10May 29, 2024 | marketbeat.comProPhase Labs: Hidden Gem With An AI KickerMay 15, 2024 | seekingalpha.comProPhase Labs (NASDAQ:PRPH) Announces Quarterly Earnings Results, Beats Expectations By $0.21 EPSProPhase Labs (NASDAQ:PRPH - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.21. The company had revenue of $3.63 million for the quarter, compared to analysts' expectations of $9.86 million. ProPhase Labs had a negative return on equity of 29.83% and a negative net margin of 37.81%. During the same period last year, the firm posted $0.03 earnings per share.May 10, 2024 | marketbeat.comProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedMay 9, 2024 | globenewswire.comProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.May 9, 2024 | finance.yahoo.comProPhase Labs (PRPH) Set to Announce Earnings on ThursdayProPhase Labs (NASDAQ:PRPH) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 3, 2024 | marketbeat.comPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9May 2, 2024 | finance.yahoo.comPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9May 2, 2024 | finance.yahoo.comProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 25, 2024 | globenewswire.comDiamond Equity Equities Analysts Cut Earnings Estimates for ProPhase Labs, Inc. (NASDAQ:PRPH)ProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Stock analysts at Diamond Equity dropped their Q1 2024 EPS estimates for ProPhase Labs in a note issued to investors on Monday, April 22nd. Diamond Equity analyst H. Diamond now forecasts that the company will post earnings per share of ($0.15) foApril 25, 2024 | marketbeat.comEquities Analysts Set Expectations for ProPhase Labs, Inc.'s Q1 2025 Earnings (NASDAQ:PRPH)ProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Investment analysts at Diamond Equity issued their Q1 2025 earnings per share (EPS) estimates for ProPhase Labs in a report issued on Monday, April 22nd. Diamond Equity analyst H. Diamond forecasts that the company will post earnings per share ofApril 24, 2024 | marketbeat.comProPhase Labs Shares Jump on New AI-Based ProjectApril 16, 2024 | marketwatch.comProPhase Labs Unveils Project ZenQ-AIApril 16, 2024 | globenewswire.comProPhase Labs, Inc.: ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024April 10, 2024 | finanznachrichten.deProPhase Flat on Cancer Drug ProgressApril 10, 2024 | baystreet.caProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024April 10, 2024 | globenewswire.comProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 1, 2024 | globenewswire.comProPhase Labs, Inc. (PRPH)April 1, 2024 | finance.yahoo.comShort Interest in ProPhase Labs, Inc. (NASDAQ:PRPH) Declines By 16.9%ProPhase Labs, Inc. (NASDAQ:PRPH - Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 248,200 shares, a decrease of 16.9% from the February 29th total of 298,500 shares. Currently, 1.8% of the company's stock are short sold. Based on an average trading volume of 26,100 shares, the short-interest ratio is currently 9.5 days.March 30, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Above 200-Day Moving Average of $4.77ProPhase Labs (NASDAQ:PRPH) Shares Cross Above 200-Day Moving Average of $4.77March 29, 2024 | marketbeat.comProPhase Labs, Inc. (NASDAQ:PRPH) Expected to Earn Q1 2024 Earnings of ($0.41) Per ShareProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Investment analysts at HC Wainwright reduced their Q1 2024 earnings per share (EPS) estimates for ProPhase Labs in a note issued to investors on Tuesday, March 19th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.41) peMarch 21, 2024 | marketbeat.comProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call TranscriptMarch 18, 2024 | finance.yahoo.comPRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023March 15, 2024 | msn.com Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now PRPH Media Mentions By Week PRPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPH News Sentiment▼-0.420.49▲Average Medical News Sentiment PRPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPH Articles This Week▼31▲PRPH Articles Average Week Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TNXP News Today VTGN News Today ALGS News Today ALXO News Today MGX News Today CTMX News Today BYSI News Today BCAB News Today ALVR News Today LPTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPH) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProPhase Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRPH Stock Alerts